CompletedNot Applicable

Total Placenta Previa Associated With the Placenta Accreta Spectrum.

Turkey (Türkiye)277 participantsStarted 2017-11-01

Plain-language summary

To assess the reliability of placental magnetic resonance imaging measurements in predicting peripartum hysterectomy and neonatal outcomes in patients with total placenta previa.

Who can participate

Age range17 Years – 42 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 27th to 37th weeks of gestation * Third trimester of pregnancy * Pregnants had received a t-PP diagnosis via color Doppler ultrasonography (cd-USG) and/or placental MRI (p-MRI). * All singleton pregnancies in which t-PP extended to both the anterior and posterior uterine walls, resulting in complete coverage of the internal cervical os by the placenta Exclusion Criteria: * Any cases of low-lying/marginal placenta previa * Preoperative hemoglobin level \< 9 g/dL * Pregnant women with coagulation disorders * Morbid obesity * Multiple fetal pregnancies * Individuals delivered before \< 27 weeks of gestation

What they're measuring

Assessment of risk factors affecting peripartum hysterectomy in placenta previa patients undergoing without MRI screening

Timeframe: Assessed during the peripartum period, within the first two days postpartum.

Clinical risk factors affecting p-TAH in patients with t-PP undergoing p-MRI.

Timeframe: Assessed during the peripartum period, within the first 2 days postpartum.

Identification of risk factors affecting neonatal mortality regardless of whether MRI scanning is used.

Timeframe: Assessed at the time of delivery.

Trial details

NCT IDNCT06219564

SponsorSaglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-06-21

View on ClinicalTrials.gov More Maternal; Procedure trials